Toggle Nav
My Cart
Search
Menu
Account
Settings
Growth Opportunities in the US Point-of-care Testing Market

Digital Health Meets Point of Care—Emergence of Mobile Molecular Diagnostics

INDUSTRY
Healthcare
SECTOR
Life Sciences

RELEASE DATE
23-Jun-2016
REGION
North America
DELIVERABLE TYPE
Market Research

RESEARCH CODE
K081-01-00-00-00
SKU
LS00263-NA-MR_18682
Yes
SHARE

Growth Opportunities in the US Point-of-care Testing Market
Published on: 23-Jun-2016 | SKU: LS00263-NA-MR_18682

Need more details?

$4,950.00

$3,712.50 save 25 %

DownloadLink
Request Sample
Add to Compare
Need more details?
Description

The US point-of-care testing (POCT) study provides an extensive analysis for 13 segments: hematology, urinalysis, infectious disease, cardiac, HbA1c, glucose, fecal occult blood test/fecal immunochemical test (FOBT/FIT), coagulation PT/INR, coagulation APTT/ACT, cholesterol, pregnancy, drugs of abuse, and blood gas and electrolytes. Key trends and market share analyses in each of these segments provide a thorough understanding of the competitive landscape. The analysis provides predictions on the future of the POCT market segments and key areas of investment that should be in the planning books for in vitro diagnostic device (IVD) companies operating in the POCT space.

Infographic
Table of Contents

Market Snapshot

Scope and Segmentation

Top Economic Motivators of Patient-centric POCT

Trends Driving POC Convergence

Trends/Factors Impacting the POCT Market

Future Trends—3 Big Predictions Driving POC Convergence

Market Definitions

POCT Tests Progression in the US

POCT Environment—Spectrum of Patient Care Testing

Market Drivers

Market Restraints

CLIA Waiver Provides Faster Access to US POCT MDx Segment with Ability to Gain more Penetration

Guide to Reimbursement—Tips from Payer Community on POCT

Retail Clinics

Global Retail Care Market Revenue—Realistic Scenario (2015–2022)

Notable Activities

Market Size and Growth Graph

Expected Penetration of POCTs

Macro to Micro Visioning

Growth Opportunities for Technology Providers

Future of POCT

Overcoming Barriers

Key Companies to Watch—Game Changers in Molecular POCT

Key Companies to Watch—Molecular Diagnostics POCT

Product Pipeline

Strategic Options for Startups in POCT

Top Predictions for the US POCT Market

The POCT Vendor Landscape

Point of Care Testing Landscape

Competitive Landscape for POCT Vendors by Test Type

Competitive Landscape for POCT Vendors by Test MethodologyCompetitor Segment Ranking Matrix

POCT Diagnostics Leaderboard

Forecast Assumptions

Revenue Forecast

Percent Revenue Forecast by Segment

Market Share Analysis

Revenue Forecast

Market Share Analysis

Product Spotlight

Market Share Analysis

Market Share Analysis

Market Share Analysis

Market Share Analysis

Market Share Analysis

Market Share Analysis

Market Share Analysis

Market Share Analysis

Market Share Analysis

Market Share Analysis

Market Share Analysis

Market Share Analysis

Alere

Enterix

Others

Partnering to Innovate—Beyond Conventional Boundaries

5 Competitive Keys for Success in POCT Space

Legal Disclaimer

Market Engineering Methodology

List of Abbreviations

List of Figures & Charts
List of Figures
  • 1. Overview of Healthcare Facilities, Serbia, 2015
  • 2. Total POCT Market: Key Market Drivers, US, 2016–2020
  • 3. Total POCT Market: Key Market Restraints, US, 2016–2020
List of Charts
  • 1. POCT Market: Percent Revenue Breakdown by Segment, US, 2016 and 2020
  • 2. Retail Care Market: Revenue Forecast, Global, 2015–2022
  • 3. POCT Market: Market Potential by Segment, US, 2015–2020
  • 4. Total POCT Market: Revenue Forecast, US, 2012–2020
  • 5. Total POCT Market: Percent Revenue Forecast by Segment, US, 2012–2020
  • 6. Total POCT Market: Market Share Evolution, US, 2012 and 2015
  • 7. Cardiac POCT Segment: Revenue Forecast, US, 2012–2020
  • 8. Cardiac POCT Segment: Percent of Sales, US, 2015
  • 9. Infectious Disease POCT Segment: Revenue Forecast, US, 2012–2020
  • 10. Infectious Disease POCT Segment: Percent of Sales, US, 2015
  • 11. Coagulation PT/INR POCT Segment: Revenue Forecast, US, 2012–2020
  • 12. Coagulation PT/INR POCT Segment: Percent of Sales, US, 2015
  • 13. Blood Gas & Electrolyte POCT Segment: Revenue Forecast, US, 2012–2020
  • 14. Blood Gas & Electrolyte POCT Segment: Percent of Sales, US, 2015
  • 15. Pregnancy POCT Segment: Revenue Forecast, US, 2012–2020
  • 16. Pregnancy POCT Segment: Percent of Sales, US, 2015
  • 17. Hematology POCT Segment: Revenue Forecast, US, 2012–2020
  • 18. Hematology POCT Segment: Percent of Sales, US, 2015
  • 19. HbA1c POCT Segment: Revenue Forecast, US, 2012–2020
  • 20. HbA1c POCT Segment: Percent of Sales, US, 2015
  • 21. Urinalysis POCT Segment: Revenue Forecast, US, 2012–2020
  • 22. Urinalysis POCT Segment: Percent of Sales, US, 2015
  • 23. Drugs of Abuse POCT Segment: Revenue Forecast, US, 2012–2020
  • 24. Drugs of Abuse POCT Segment: Percent of Sales, US, 2015
  • 25. Coagulation ACT/APTT POCT Segment: Revenue Forecast, US, 2012–2020
  • 26. Coagulation ACT/APTT POCT Segment: Percent of Sales, US, 2015
  • 27. Blood Glucose POCT Segment: Revenue Forecast, US, 2012–2020
  • 28. Blood Glucose POCT Segment: Percent of Sales, US, 2015
  • 29. Cholesterol POCT Segment: Revenue Forecast, US, 2012–2020
  • 30. Cholesterol POCT Segment: Percent of Sales, US, 2015
  • 31. FOBT/FIT POCT Segment: Revenue Forecast, US, 2012–2020
  • 32. FOBT/FIT POCT Segment: Percent of Sales, US, 2015
Request Sample

Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Life Sciences research

13 Jan 2025   |   Global   |   Market Outlook

Top 6 Growth Opportunities for the Digital Health Industry, 2025

Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...

17 Dec 2024   |   Global   |   Market Research

Cybersecurity in Healthcare, United States, 2024

Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...

12 Dec 2024   |   Global   |   Market Outlook

Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025

Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...

05 Dec 2024   |   Global   |   Frost Radar

Frost Radar™: Enterprise Conversational AI in Healthcare, 2024

This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...

27 Nov 2024   |   Global   |   Market Research

Generative AI in Payer and Provider IT Transformation, Global, 2024-2029

The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts
Related Research
  1. Global Clinical Diagnostics Industry Growth Opportunities, 2026–2031
    Release Date: 25-Mar-26
  2. Smartphone-based Solutions Spur the Global Infectious Disease Point-of-Care Testing Market, Forecast to 2024
    Release Date: 14-Sep-20
  3. Growth Insights for European Infectious Disease Point-of-Care Testing (POCT) Market, Forecast to 2022
    Release Date: 25-Jun-18
  4. US Point-of-Care Testing Infectious Disease Market, Forecast to 2022
    Release Date: 05-Oct-18
  5. Western Europe Point-of-Care Testing (POCT) Market
    Release Date: 1-Jul-2016

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

The US point-of-care testing (POCT) study provides an extensive analysis for 13 segments: hematology, urinalysis, infectious disease, cardiac, HbA1c, glucose, fecal occult blood test/fecal immunochemical test (FOBT/FIT), coagulation PT/INR, coagulation APTT/ACT, cholesterol, pregnancy, drugs of abuse, and blood gas and electrolytes. Key trends and market share analyses in each of these segments provide a thorough understanding of the competitive landscape. The analysis provides predictions on the future of the POCT market segments and key areas of investment that should be in the planning books for in vitro diagnostic device (IVD) companies operating in the POCT space.
More Information
Deliverable Type Market Research
No Index No
Podcast No
Table of Contents | Executive Summary~ || Market Snapshot~ || Scope and Segmentation~ || Top Economic Motivators of Patient-centric POCT~ || Trends Driving POC Convergence~ || Trends/Factors Impacting the POCT Market~ || Future Trends—3 Big Predictions Driving POC Convergence~ | Market Overview~ || Market Definitions~ || POCT Tests Progression in the US~ || POCT Environment—Spectrum of Patient Care Testing~ || Market Drivers~ || Market Restraints~ || CLIA Waiver Provides Faster Access to US POCT MDx Segment with Ability to Gain more Penetration~ || Guide to Reimbursement—Tips from Payer Community on POCT~ || Retail Clinics~ || Global Retail Care Market Revenue—Realistic Scenario (2015–2022)~ || Notable Activities~ || Market Size and Growth Graph~ || Expected Penetration of POCTs~ | Vision and Strategy—Growth Opportunities~ || Macro to Micro Visioning~ || Growth Opportunities for Technology Providers~ || Future of POCT~ || Overcoming Barriers~ || Key Companies to Watch—Game Changers in Molecular POCT~ ||| QuantuMDx~ ||| Ubiquitome~ ||| LucigenDx~ ||| GenePOC Diagnostics~ || Key Companies to Watch—Molecular Diagnostics POCT~ ||| Insilixa~ ||| Oxford Nanopore~ ||| DNA Electronics~ || Product Pipeline~ || Strategic Options for Startups in POCT~ || Top Predictions for the US POCT Market~ | Competitive Analysis~ || The POCT Vendor Landscape~ || Point of Care Testing Landscape~ || Competitive Landscape for POCT Vendors by Test Type~ || Competitive Landscape for POCT Vendors by Test MethodologyCompetitor Segment Ranking Matrix~ || POCT Diagnostics Leaderboard~ | Market Forecasts~ || Forecast Assumptions~ || Revenue Forecast~ || Percent Revenue Forecast by Segment~ || Market Share Analysis~ ||| Alere~ ||| Roche Diagnostics~ ||| Abbott Diagnostics~ ||| Siemens~ ||| Others~ | Cardiac POCT Segment~ || Revenue Forecast~ || Market Share Analysis~ ||| Alere~ ||| Roche~ ||| Siemens~ ||| Others~ || Product Spotlight~ | Infectious Disease POCT Segment~ || Market Share Analysis~ ||| Alere~ ||| Quidel~ ||| Meridien~ ||| Orasure~ ||| Others~ | Coagulation PT/INR POCT Segment~ || Market Share Analysis~ ||| Roche Diagnostics~ ||| Alere~ ||| Philips~ ||| Abbott Diagnostics~ ||| Others~ | Blood Gas & Electrolyte POCT Segment~ || Market Share Analysis~ ||| Abbott Laboratories~ ||| Radiometer~ ||| Siemens Healthcare Diagnostics~ ||| Instrumentation Laboratory~ ||| Roche~ ||| Others~ | Pregnancy POCT Segment~ || Market Share Analysis~ ||| Alere~ ||| Quidel~ ||| Beckman Coulter~ ||| Others~ | Hematology POCT Segment~ || Market Share Analysis~ ||| HemoCue~ ||| Abbott~ ||| Stanbio~ ||| Others~ | HbA1c POCT Segment~ || Market Share Analysis~ ||| Siemens~ ||| Alere~ ||| PTS Diagnostics~ ||| Others~ | Urinalysis POCT Segment~ || Market Share Analysis~ ||| Siemens~ ||| Roche~ ||| Arkray~ ||| Others~ | Drugs of Abuse POCT Segment~ || Market Share Analysis~ ||| Alere~ ||| Medtox~ ||| Others~ | Coagulation ACT/APTT POCT Segment~ || Market Share Analysis~ ||| Medtronic~ ||| Abbott~ ||| HelenaLaboratories~ ||| Accriva Diagnostics~ | Blood Glucose POCT Segment~ || Market Share Analysis~ ||| Roche~ ||| HemoCue~ ||| Nova Biomedical~ ||| Abbott~ ||| Others~ | Cholesterol POCT Segment~ || Market Share Analysis~ ||| Alere~ ||| PTS Diagnostics~ ||| Roche~ | FOBT/FIT POCT Segment~ || Market Share Analysis~ ||| Beckman Coulter~ || Alere~ || Enterix~ || Others~ | Conclusions~ || Partnering to Innovate—Beyond Conventional Boundaries~ || 5 Competitive Keys for Success in POCT Space~ || Legal Disclaimer~ | Appendix~ || Market Engineering Methodology~ || List of Abbreviations~
List of Charts and Figures 1. Overview of Healthcare Facilities, Serbia, 2015 ~ 2. Total POCT Market: Key Market Drivers, US, 2016–2020~ 3. Total POCT Market: Key Market Restraints, US, 2016–2020~| 1. POCT Market: Percent Revenue Breakdown by Segment, US, 2016 and 2020~ 2. Retail Care Market: Revenue Forecast, Global, 2015–2022~ 3. POCT Market: Market Potential by Segment, US, 2015–2020 ~ 4. Total POCT Market: Revenue Forecast, US, 2012–2020~ 5. Total POCT Market: Percent Revenue Forecast by Segment, US, 2012–2020~ 6. Total POCT Market: Market Share Evolution, US, 2012 and 2015~ 7. Cardiac POCT Segment: Revenue Forecast, US, 2012–2020~ 8. Cardiac POCT Segment: Percent of Sales, US, 2015~ 9. Infectious Disease POCT Segment: Revenue Forecast, US, 2012–2020~ 10. Infectious Disease POCT Segment: Percent of Sales, US, 2015~ 11. Coagulation PT/INR POCT Segment: Revenue Forecast, US, 2012–2020~ 12. Coagulation PT/INR POCT Segment: Percent of Sales, US, 2015~ 13. Blood Gas & Electrolyte POCT Segment: Revenue Forecast, US, 2012–2020~ 14. Blood Gas & Electrolyte POCT Segment: Percent of Sales, US, 2015~ 15. Pregnancy POCT Segment: Revenue Forecast, US, 2012–2020~ 16. Pregnancy POCT Segment: Percent of Sales, US, 2015~ 17. Hematology POCT Segment: Revenue Forecast, US, 2012–2020~ 18. Hematology POCT Segment: Percent of Sales, US, 2015~ 19. HbA1c POCT Segment: Revenue Forecast, US, 2012–2020~ 20. HbA1c POCT Segment: Percent of Sales, US, 2015~ 21. Urinalysis POCT Segment: Revenue Forecast, US, 2012–2020~ 22. Urinalysis POCT Segment: Percent of Sales, US, 2015~ 23. Drugs of Abuse POCT Segment: Revenue Forecast, US, 2012–2020~ 24. Drugs of Abuse POCT Segment: Percent of Sales, US, 2015~ 25. Coagulation ACT/APTT POCT Segment: Revenue Forecast, US, 2012–2020~ 26. Coagulation ACT/APTT POCT Segment: Percent of Sales, US, 2015~ 27. Blood Glucose POCT Segment: Revenue Forecast, US, 2012–2020~ 28. Blood Glucose POCT Segment: Percent of Sales, US, 2015~ 29. Cholesterol POCT Segment: Revenue Forecast, US, 2012–2020~ 30. Cholesterol POCT Segment: Percent of Sales, US, 2015~ 31. FOBT/FIT POCT Segment: Revenue Forecast, US, 2012–2020~ 32. FOBT/FIT POCT Segment: Percent of Sales, US, 2015~
Author Divyaa Ravishankar
WIP Number K081-01-00-00-00
Is Prebook No

Growth Opportunities in the US Point-of-care Testing Market

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
LS00263-NA-MR_18682